The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
The FDA approved a one-time, five-minute IV bolus infusion of tenecteplase for ... Ophthalmology and Internal Medicine at Genentech, told Healio. “This milestone strengthens our commitment ...
[27] We consider the use of a single-dose intravenous salbutamol bolus in the ED to be more effective in achieving earlier clinical response in a subgroup of children with acute severe asthma.
compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...
TNKase is delivered as a single five-second intravenous bolus. This is considerably faster than the standard of care, Activase (alteplase), which is administered as an intravenous bolus followed by a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback